September 1, 2017 / 11:19 AM / 24 days ago

BRIEF-Forward Pharma board approves capital reduction

Sept 1 (Reuters) - Forward Pharma A/S

* Forward Pharma board of directors approves capital reduction and returns EUR 917.7 million to shareholders

* Forward Pharma A/S - the company effected the capital reduction with a distribution of proceeds to holders of ordinary shares‍​

* Forward Pharma A/S - ‍record date for holders of ADS to receive a ratable portion of capital reduction will be September 7, 2017​

* Forward Pharma A/S - ‍ADSs are expected to begin trading “ex-dividend” on September 12, 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below